Jones William A Jr - Net Worth and Insider Trading

Jones William A Jr Net Worth

The estimated net worth of Jones William A Jr is at least $24,710 dollars as of 2024-06-06. Jones William A Jr is the CCO-Migraine & Common Disease of Biohaven Pharmaceutical Holding Co Ltd and owns about 1,755 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $24,710. Details can be seen in Jones William A Jr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jones William A Jr has not made any transactions after 2020-11-02 and currently still holds the listed stock(s).

Transaction Summary of Jones William A Jr

Jones William A Jr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jones William A Jr owns 3 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) , Akili Inc (AKLI) , and Apogee Therapeutics Inc (APGE) .

Click here to see the complete history of Jones William A Jr’s form 4 insider trades.

Insider Ownership Summary of Jones William A Jr

Ticker	Comapny	Transaction Date	Type of Owner
BHVN	Biohaven Pharmaceutical Holding Co Ltd	2020-11-02	CCO-Migraine & Common Disease
AKLI	Akili Inc	2022-08-19	director
APGE	Apogee Therapeutics Inc	2023-07-13	director

Jones William A Jr Latest Holdings Summary

Jones William A Jr currently owns a total of 1 stock. Jones William A Jr owns 1,755 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of November 2, 2020, with a value of $24,710.

Latest Holdings of Jones William A Jr

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
BHVN	Biohaven Pharmaceutical Holding Co Ltd	2020-11-02	1,755	14.08	24,710

Holding Weightings of Jones William A Jr

Jones William A Jr Form 4 Trading Tracker

According to the SEC Form 4 filings, Jones William A Jr has made a total of 1 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the sale of 30,000 shares on November 2, 2020, which brought Jones William A Jr around $2 Million.

Insider Trading History of Jones William A Jr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jones William A Jr Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jones William A Jr Ownership Network

Ownership Network List of Jones William A Jr

No Data

Ownership Network Relation of Jones William A Jr

Jones William A Jr Owned Company Details

What does Biohaven Pharmaceutical Holding Co Ltd do?

Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?

Jones William A Jr is the CCO-Migraine & Common Disease of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include VP & Chief Accounting Officer George C. Clark , Chief Medical Officer Elyse Stock , and Chief Financial Officer James Engelhart .

Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Biohaven Pharmaceutical Holding Co Ltd Insider Transactions

No Available Data

What does Akili Inc do?

Who are the key executives at Akili Inc?

Jones William A Jr is the director of Akili Inc. Other key executives at Akili Inc include Chief Legal Officer Jacqueline Studer , See Remarks Matthew Franklin , and director & Chief Executive Officer Martucci Walter Edward Ii .

Akili Inc (AKLI) Insider Trades Summary

Over the past 18 months, Jones William A Jr made no insider transaction in Akili Inc (AKLI). Other recent insider transactions involving Akili Inc (AKLI) include a net sale of 2,353 shares made by Martucci Walter Edward Ii , a net sale of 1,728 shares made by Matthew Franklin , and a net sale of 1,130 shares made by Jacqueline Studer .

In summary, during the past 3 months, insiders sold 0 shares of Akili Inc (AKLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,041 shares of Akili Inc (AKLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,041 shares.

Akili Inc (AKLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Akili Inc Insider Transactions

No Available Data

What does Apogee Therapeutics Inc do?

Who are the key executives at Apogee Therapeutics Inc?

Jones William A Jr is the director of Apogee Therapeutics Inc. Other key executives at Apogee Therapeutics Inc include Chief Financial Officer Jane Henderson , director & Chief Executive Officer Michael Thomas Henderson , and Chief Medical Officer Carl Dambkowski .

Apogee Therapeutics Inc (APGE) Insider Trades Summary

Over the past 18 months, Jones William A Jr made no insider transaction in Apogee Therapeutics Inc (APGE). Other recent insider transactions involving Apogee Therapeutics Inc (APGE) include a net purchase of 2,941,176 shares made by Fairmount Healthcare Fund L.p. , and a net purchase of 1,750,000 shares made by Nimish P Shah .

In summary, during the past 3 months, insiders sold 0 shares of Apogee Therapeutics Inc (APGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Apogee Therapeutics Inc (APGE) were sold and 4,691,176 shares were bought by its insiders, resulting in a net purchase of 4,691,176 shares.

Apogee Therapeutics Inc (APGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Apogee Therapeutics Inc Insider Transactions

No Available Data

Jones William A Jr Mailing Address

Above is the net worth, insider trading, and ownership report for Jones William A Jr. You might contact Jones William A Jr via mailing address: Nitromed, Inc., 125 Spring Street, Lexington Ma 02421.

Discussions on Jones William A Jr

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.